For this reason, a majority of these immunomodulatory studies get direct reference to viral infections or immune evasion, at the entry stage, which are to a great extent, centric to the interaction of the viral spike glycoproteins with such cellular receptors and co-receptors. This evidence concerns the gene AQP1 and viral infectious disease.